Evotec announces metabolic disease alliance with MedImmune

21-Dec-2010 - Evotec AG announced that via its subsidiary Develogen AG it has entered into a license and collaboration agreement with MedImmune (the global biologics unit of AstraZeneca), in the diabetes therapeutic area, with a particular focus on the regeneration of insulin producing beta cells. The license ...

Evotec Completes Acquisition of DeveloGen

03-Sep-2010 - Following the successful fulfilment of various Closing conditions, the sellers of 99.3% of the shares in DeveloGen AG transferred their shares to Evotec AG. Evotec AG issues 6,750,014 new Evotec Shares from its authorized capital as part consideration for the transaction. Following the ...

DeveloGen AG receives US$ 500.000 Funding from the Juvenile Diabetes Research Foundation for Beta Cell Research

25-Feb-2010 - DeveloGen AG announced that it will receive US$ 500,000 from the Juvenile Diabetes Research Foundation, New York, USA (JDRF). The funds are dedicated to aide in the research of mechanisms for the protection of beta cells. In this two year project titled "Development of Novel Therapeutic Agents ...

DeveloGen Reports Positive Phase 1 Clinical Trial Results for DG3173

02-Mar-2009 - DeveloGen AG reported positive results from a Phase 1 study for DG3173, a novel somatostatin analogue. The results of the study indicate that DG3173 has an excellent safety and tolerability profile at all doses administered. The Phase 1 trial was designed as a randomized, double-blind, placebo ...

Peptor an Develogen announce intention to merge

20-Nov-2003 - Peptor Ltd., a biopharmaceutical company engaged in discovery and development of immunotherapeutic drugs to treat diabetes and other autoimmune diseases, and DeveloGen AG, a biology-driven drug discovery company developing novel therapies for diabetes and obesity, announced today that the boards ...

DeveloGen and Scientists from IPK Gatersleben Publish Data on Key Trigger for Regenerating Insulin Producing Cells

Study Provides Additional Support in Fight to Treat Diabetes

20-Jan-2003 - DeveloGen AG announced the publication of important new diabetes data in the current early edition of Proceedings of the National Academy of Sciences. The study demonstrates the ability to normalize blood glucose levels in mice using insulin-secreting cells generated in a procedure driven by the ...